These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 27919826)

  • 1. Should blood pressure goal be individualized in hypertensive patients?
    Yannoutsos A; Kheder-Elfekih R; Halimi JM; Safar ME; Blacher J
    Pharmacol Res; 2017 Apr; 118():53-63. PubMed ID: 27919826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood pressure target in 2017].
    Yannoutsos A; Bura-Rivière A; Priollet P; Blacher J
    J Med Vasc; 2017 Dec; 42(6):367-374. PubMed ID: 29203043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
    Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
    Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving blood pressure control targets in hypertensive patients of rural China - a pilot randomized trial.
    Huang X; Liu L; Song Y; Gao L; Zhao M; Bao H; Qin X; Wu Y; Wu Q; Bi C; Yue A; Fang C; Ma H; Cui Y; Tang G; Li P; Zhang Y; Li J; Wang B; Xu X; Wang H; Parati G; Spence JD; Wang X; Huo Y; Chen G; Cheng X;
    Trials; 2020 Jun; 21(1):515. PubMed ID: 32527283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
    Bangalore S; Kumar S; Lobach I; Messerli FH
    Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.
    Bangalore S; Kumar S; Volodarskiy A; Messerli FH
    Heart; 2013 May; 99(9):601-13. PubMed ID: 22914531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between blood pressure lowering therapy and cardiovascular events in hypertensive patients with coronary artery disease and type 2 diabetes mellitus: The HIJ-CREATE sub-study.
    Kamishima K; Ogawa H; Jujo K; Yamaguchi J; Hagiwara N
    Diabetes Res Clin Pract; 2019 Mar; 149():69-77. PubMed ID: 30735770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
    Ramsay L; Williams B; Johnston G; MacGregor G; Poston L; Potter J; Poulter N; Russell G
    J Hum Hypertens; 1999 Sep; 13(9):569-92. PubMed ID: 10482967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT.
    Juraschek SP; Taylor AA; Wright JT; Evans GW; Miller ER; Plante TB; Cushman WC; Gure TR; Haley WE; Moinuddin I; Nord J; Oparil S; Pedley C; Roumie CL; Whittle J; Wiggers A; Finucane C; Anne Kenny R; Appel LJ; Townsend RR;
    Hypertension; 2020 Mar; 75(3):660-667. PubMed ID: 31983312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Bhatt H; Ghazi L; Calhoun D; Oparil S
    Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
    Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
    Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the SPRINT Trial on Hypertension Management.
    Ghazi L; Oparil S
    Annu Rev Med; 2018 Jan; 69():81-95. PubMed ID: 29414255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Versus Less Blood Pressure Lowering: An Update.
    Atkins ER; Rodgers A
    Clin Ther; 2016 Oct; 38(10):2135-2141. PubMed ID: 27633256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial.
    McManus RJ; Mant J; Haque MS; Bray EP; Bryan S; Greenfield SM; Jones MI; Jowett S; Little P; Penaloza C; Schwartz C; Shackleford H; Shovelton C; Varghese J; Williams B; Hobbs FD; Gooding T; Morrey I; Fisher C; Buckley D
    JAMA; 2014 Aug; 312(8):799-808. PubMed ID: 25157723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT).
    Agarwal R
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.